WindMIL Therapeutics Company
WindMIL Therapeutics translates novel insights in bone marrow immunology into life-saving cell therapies for cancer patients.
Technology:
CAR-T therapy
Industry:
Private
Headquarters:
Princeton, New Jersey, United States
Founded Date:
2015-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
42500000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018-06-18
Last Funding Type:
Series B
Register and Claim Ownership